BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

Genome & Company Advances Phase II Trial After Positive Interim Analysis, Proceeds to Second Stage

Genome & Company (CEO: Pae, Jisoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT05419362) will continue ...

May 22, 2023 | News

Gencurix Reports Clinical Results of 15-Year Follow-Up Prognostic Test for Cancer Patients in Korea and Japan

Gencurix announced clinical results of its prognostic test for breast cancer patients at the Global Breast Cancer Conference 2023. The study, 'Long-te...

May 10, 2023 | News

MEDICAL IP utilizes NVIDIA Omniverse to develop virtual Medical Digital Twins

MEDIP PRO, a real-time digital twin implementation solution based on medical imaging, is now connected to NVIDIA Omniverse Maximize medical data...

May 09, 2023 | News

Merck to Establish BioProcessing Production Center in South Korea with Ministry and Daejeon City

MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daej...

May 03, 2023 | News

Toshiba's Heavy Ion Therapy System treats patients at Yonsei University Health System.

Toshiba Energy Systems & Solutions Corporation (hereinafter "Toshiba ESS") is pleased to announce today the commencement of treatment using a heavy ion...

April 30, 2023 | News

Daewoong Pharma partners with Vitalli Bio for new autoimmune drug (DWP213388)

Exclusive rights for the development and commercialization of DWP213388 in the global market to Vitalli Bio, a portfolio company of Aditum Bio, the biotech...

April 28, 2023 | News

Indica Labs and Lunit Form Strategic Alliance for Integrated Digital Pathology AI Workflows

Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform compa...

April 27, 2023 | News

MGI Announces New Customer Experience Center in South Korea with BMS

"Genomics is an exploding and popular field in South Korea, and we at MGI are excited to join hands with BMS to welcome researchers and partners in th...

April 27, 2023 | News

Agilent and Theragen Bio Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea

Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to ...

April 26, 2023 | News

Bridge Biotherapeutics Receives FDA Approval for First-in-Human Study of BBT-207, a 4th Gen EGFR TKI.

The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed The latest preclinical data explored the antitumor effica...

April 24, 2023 | News

Samyang Holdings partners with LG Chem for innovative cancer therapeutics.

Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on Thursday, April 20th, for development of nove...

April 20, 2023 | News

Korea Health Industry Development Institute hosts Korean Pavilion at 2023 HIMSS Global Health Conference

Korea Health Industry Development Institute (President Cha Soon-do, hereinafter referred to as the "Institute") announced that they will run the Korea...

April 19, 2023 | News

West Korea Announces Ready Pack™ Containment Solution Extension at COPHEX 2023

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced the extension o...

April 18, 2023 | News

Bridge Bio Announces First Patient Dosed in Phase 2a Trial of BBT-877 for Idiopathic Pulmonary Fibrosis Treatment

In the Phase 1 study in 2019, BBT-877, a potent autotaxin (ATX) inhibitor, demonstrated its ability to inhibit lysophosphatidic acid (LPA) production by as...

April 13, 2023 | News

Stay Connected